A comprehensive view of non-vaccine biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck to acquire the University at Buffalo startup Abceutics for up to US$280.0M in a bid to enhance its antibody-drug conjugate pipeline; Abceutics is developing technology aimed at reducing the impact of therapies on healthy cells

FDA approves J&J’s CARVYKTI to treat patients with relapsed or refractory multiple myeloma who have received at least one prior line of therapy; an estimated 35,000 cases of the disease projected to be diagnosed this year in US

Becker's Hospital Review Underscores Industry Shifts with Vaccine Updates, Strikes, Legal Battles, Financial Challenges, Work-Life Reforms, Cyber Responses, and Pricing Scrutiny

Regeneron announces formation of Regeneron Cell Medicines with the acquisition of 2seventy bio's full development and commercialization rights for novel immune cell therapies, along with discovery and clinical manufacturing capabilities

Monash University, Moderna create the Monash-Moderna Quantitative Pharmacology Accelerator, a five-year program to drive mRNA medicine advancements, including therapeutics and vaccines; Moderna invests $3.0M in the Australia-based partnership

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count